BMP1 inhibitor UK-383,367 attenuates renal fibrosis and inflammation in CKD.

@article{Bai2019BMP1IU,
  title={BMP1 inhibitor UK-383,367 attenuates renal fibrosis and inflammation in CKD.},
  author={Mi Bai and Juan Lei and Shuqin Wang and Dan Ding and Xiaowen Yu and Yan Guo and Shuang Chen and Yang Du and de Oliveira Li and Yue Zhang and Songming Huang and Zhanjun Jia and Aihua Zhang},
  journal={American journal of physiology. Renal physiology},
  year={2019}
}
  • M. Bai, Juan Lei, A. Zhang
  • Published 1 December 2019
  • Medicine, Biology, Chemistry
  • American journal of physiology. Renal physiology
Renal fibrosis is a key pathological phenomenon of chronic kidney disease (CKD), contributing to the progressive loss of renal function. UK383,367 is a procollagen C-proteinase inhibitor that has been selected as a candidate for dermal anti-scarring agent, while its role in renal fibrosis is unclear. In this study, UK383,367 was applied to a CKD mouse model of unilateral ureteral obstruction (UUO) and cell lines of renal tubular epithelial cells (mPTCs) and renal fibroblast cells (NRK-49F… 
BMP1 is not required for lung fibrosis in mice
TLDR
It is proposed that B MP1 is not required for lung fibrosis in mice and BMP1 may not be considered a candidate therapeutic target for IPF.
PSC-MSC-Derived Exosomes Protect against Kidney Fibrosis In Vivo and In Vitro through the SIRT6/β-Catenin Signaling Pathway
TLDR
It is found that PSC-MSC-derived exosomes could prevent the epithelial differentiation of NRK-52E cells, and with increasing exosome concentrations, the effect was improved.
First Characterization of ADAMTS-4 in Kidney Tissue and Plasma of Patients with Chronic Kidney Disease—A Potential Novel Diagnostic Indicator
TLDR
Native kidney and kidney transplant samples as well as plasma from patients with various stages of CKD were compared to controls and metzincin protease ADAMTS-4 might have a significant role in CKD as a potential novel diagnostic indicator.
Ginsenoside Rg1 attenuates LPS-induced chronic renal injury by inhibiting NOX4-NLRP3 signaling in mice.
The inhibition of bone morphogenetic protein 1 attenuates endometriosis lesions in vivo and in vitro
TLDR
The hypothesis that the inhibition of BMP1 is involved in the pathogenesis of endometriosis lesions is supported.
Expression profile analysis to predict potential biomarkers for glaucoma: BMP1, DMD and GEM
TLDR
Several key genes, including BMP1, DMD and GEM, that may be involved in the pathogenesis of glaucoma are identified and may help to determine the prognosis of glAUcoma and/or to design gene- or molecule-targeted drugs.

References

SHOWING 1-10 OF 32 REFERENCES
Systemic inhibition of BMP1-3 decreases progression of CCl4-induced liver fibrosis in rats
TLDR
The results suggest that BMP1-3 inhibitors have significant potential for decreasing the progression of fibrosis in liver cirrhosis.
Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies.
TLDR
It is essential to improve the knowledge of the cellular and molecular mechanisms of the progress of renal fibrosis in order to achieve a reversion/elimination of kidney fibrosis.
Circulating bone morphogenetic protein 1-3 isoform increases renal fibrosis.
TLDR
In rats with CKD, administration of recombinant BMP1-3 increased renal fibrosis and reduced survival, while administration of a BMP 1-3-neutralizing antibody reduced kidney fibrosis, preserved renal function, and increased survival.
Obstructive nephropathy and renal fibrosis.
TLDR
Most of the evidence suggests that the rodent model of UUO is reflective of human renal disease processes.
Cellular and molecular mechanisms of renal fibrosis
  • Youhua Liu
  • Biology, Medicine
    Nature Reviews Nephrology
  • 2011
TLDR
The current understanding of the cellular and molecular mechanisms of renal fibrosis is outlined, which could offer novel insights into the development of new therapeutic strategies.
Macrophages: versatile players in renal inflammation and fibrosis
TLDR
The induction of MMT, via the Src-centric regulatory network mediated by transforming growth factor-β1 (TGFβ1)–Smad3, serves as a key checkpoint in the progression of chronic inflammation to renal fibrosis.
Recent advances in understanding of chronic kidney disease
TLDR
Recent advances in genome editing technologies and stem cell research give great insights to understand the pathogenesis of CKD, including identifications of the origins of renal myofibroblasts and tubular epithelial cells upon injury.
The inflammatory component in progressive renal disease--are interventions possible?
  • I. Noronha, C. Fujihara, R. Zatz
  • Medicine, Biology
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2002
TLDR
The development of progressive renal damage occurs even after resolution of the initial insult suggesting that this cascade of events occurring in the tubulointerstitium, once triggered, has an autonomic and progressive pattern.
...
...